JAN 15, 2020 1:04 PM PST

Treating Malaria: Molecular Understanding of Drug Interactions

WRITTEN BY: Nouran Amin

Crystallization is a process central to drug development that despite centuries of facilitating a particular method, chemists are still learning how to grasp the complexity of drug interactions that involve the building and dissolution of crystals.

For the very first time, researchers have reported in the journal Nature what occurs at the molecular level when two compounds inhibit the growth of crystals. In the study, researchers examine these interactions between two antimalarial drugs

"You would expect using two drugs that attacked crystallization in two different ways would be synergistic, or at the very least additive," said Jeffrey Rimer, Abraham E. Dukler Professor of Chemical and Biomolecular Engineering at UH and a co-author of the paper. "Instead, we found that they can work against each other."

When drugs work against each other, this is known as antagonistic cooperation and can result in an infective treatment. In the case of the study, researchers were hopeful to treat Malaria by first understanding the molecular level of drug targets.

Malaria is a mosquito-borne disease that is often fatal killing more children than adults. It is caused by a parasite that devours the oxygen-carrying molecule found in our blood, hemoglobin. When it does so, it leaves behind a compound known as ‘hematin’ that the parasite sequesters into a crystal.

In the study, researchers examined the growth of hematin crystals using for common antimalarial drugs---- chloroquine, quinine, mefloquine and amodiaquine. They were able to characterize the mechanisms that these compounds utilize to inhibit crystal growth.

"This mechanism may provide guidance in the search for suitable inhibitor combinations to control crystallization of pathological, biomimetic, and synthetic materials," the researchers wrote. "In a broader context, our results highlight modifier interactions mediated by the dynamics and structures on the crystal interface as a prime element of the regulation of the shapes and patterns of crystalline structures in nature and industry."

Learn more about Malaria:

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 21, 2020
Drug Discovery & Development
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
SEP 21, 2020
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
The World Health Organization has endorsed a protocol to put African herbal medicines through clinical trials as possibl ...
OCT 01, 2020
Drug Discovery & Development
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
OCT 01, 2020
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and ...
OCT 13, 2020
Immunology
Early Tips For Cell & Gene Therapy Regulatory Compliance
OCT 13, 2020
Early Tips For Cell & Gene Therapy Regulatory Compliance
Cell and gene therapies hold great promise for improved health outcomes. Now is the time to advance life-saving research ...
OCT 12, 2020
Microbiology
Researchers May Have Found a Way to Cure Rotavirus Infections
OCT 12, 2020
Researchers May Have Found a Way to Cure Rotavirus Infections
Rotaviruses are very contagious. They are the most common cause of diarrhea in children and are estimated to cause about ...
OCT 29, 2020
Drug Discovery & Development
Scientists Create Antibiotic from Komodo Dragon Blood
OCT 29, 2020
Scientists Create Antibiotic from Komodo Dragon Blood
Researchers from George Mason University in Washington DC have created a synthetic molecule from Komodo Dragon blood tha ...
NOV 04, 2020
Cancer
Building a New Chemotherapy Drug
NOV 04, 2020
Building a New Chemotherapy Drug
For decades, modern medicine has relied on chemists’ work to produce compounds that could one day be used as a dru ...
Loading Comments...